RU2017145630A3 - - Google Patents
Download PDFInfo
- Publication number
- RU2017145630A3 RU2017145630A3 RU2017145630A RU2017145630A RU2017145630A3 RU 2017145630 A3 RU2017145630 A3 RU 2017145630A3 RU 2017145630 A RU2017145630 A RU 2017145630A RU 2017145630 A RU2017145630 A RU 2017145630A RU 2017145630 A3 RU2017145630 A3 RU 2017145630A3
- Authority
- RU
- Russia
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
- A61K31/431—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems containing further heterocyclic rings, e.g. ticarcillin, azlocillin, oxacillin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
- A61K31/546—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine containing further heterocyclic rings, e.g. cephalothin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
- A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/7036—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/38—Chemical stimulation of growth or activity by addition of chemical compounds which are not essential growth factors; Stimulation of growth by removal of a chemical compound
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Dispersion Chemistry (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Cephalosporin Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1511058.8A GB201511058D0 (en) | 2015-06-23 | 2015-06-23 | Compositions and methods for using lamellar bodies for therapeutic purposes |
GB1511058.8 | 2015-06-23 | ||
PCT/GB2016/051890 WO2016207645A1 (en) | 2015-06-23 | 2016-06-23 | Compositions and methods for using lamellar bodies for therapeutic purposes |
Publications (2)
Publication Number | Publication Date |
---|---|
RU2017145630A RU2017145630A (ru) | 2019-07-23 |
RU2017145630A3 true RU2017145630A3 (ru) | 2019-07-24 |
Family
ID=53784408
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2017145630A RU2017145630A (ru) | 2015-06-23 | 2016-06-23 | Композиции и способы для применения ламеллярных телец в терапевтических целях |
Country Status (24)
Country | Link |
---|---|
US (1) | US20180169145A1 (ru) |
EP (2) | EP3313377B1 (ru) |
JP (1) | JP2018518538A (ru) |
KR (1) | KR20180036958A (ru) |
CN (1) | CN107920994A (ru) |
AU (1) | AU2016281764A1 (ru) |
BR (1) | BR112017027899A2 (ru) |
CA (1) | CA2990743A1 (ru) |
DK (1) | DK3313377T3 (ru) |
ES (1) | ES2754436T3 (ru) |
GB (1) | GB201511058D0 (ru) |
HK (1) | HK1248136A1 (ru) |
HR (1) | HRP20192091T1 (ru) |
HU (1) | HUE046510T2 (ru) |
IL (1) | IL256498A (ru) |
LT (1) | LT3313377T (ru) |
MX (1) | MX2018000040A (ru) |
PH (1) | PH12017502432A1 (ru) |
PL (1) | PL3313377T3 (ru) |
PT (1) | PT3313377T (ru) |
RS (1) | RS59551B1 (ru) |
RU (1) | RU2017145630A (ru) |
WO (1) | WO2016207645A1 (ru) |
ZA (1) | ZA201800372B (ru) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3781123A1 (en) * | 2018-04-17 | 2021-02-24 | Lamellar Biomedical Limited | Antifibrotic composition |
CN114910325A (zh) * | 2022-05-17 | 2022-08-16 | 浙江峻山生物科技有限公司 | 一种人工模拟痰液及其制备方法 |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5925375A (en) * | 1987-05-22 | 1999-07-20 | The Liposome Company, Inc. | Therapeutic use of multilamellar liposomal prostaglandin formulations |
US5403592A (en) * | 1987-08-25 | 1995-04-04 | Macnaught Pty Limited | Lubricant composition for rheumatism |
AU2943389A (en) * | 1988-01-13 | 1989-08-11 | Upjohn Company, The | Enhanced production of cellular proteins using butyrate |
WO1991012026A1 (en) * | 1990-02-14 | 1991-08-22 | Macnaught Pty Limited | Means of reducing surgical adhesions |
US5741516A (en) * | 1994-06-20 | 1998-04-21 | Inex Pharmaceuticals Corporation | Sphingosomes for enhanced drug delivery |
US5462752A (en) * | 1994-07-28 | 1995-10-31 | Prp, Inc. | Inhibition of platelet binding |
WO1998053800A1 (en) * | 1997-05-29 | 1998-12-03 | Applied Biotechnologies, Inc. | Compositions and methods for preventing adhesion |
GB9807298D0 (en) * | 1998-04-03 | 1998-06-03 | Britannia Pharmaceuticals Ltd | Medicament |
CA2319928A1 (en) * | 2000-09-18 | 2002-03-18 | Vasogen Ireland Limited | Apoptosis-mimicking synthetic entities and use thereof in medical treatments |
US8541472B2 (en) * | 2001-12-05 | 2013-09-24 | Aseptica, Inc. | Antiseptic compositions, methods and systems |
US7498292B2 (en) * | 2002-08-15 | 2009-03-03 | The Research Foundation Of State University Of New York | Combinatorial libraries of autoinducer analogs, autoinducer agonists and antagonists, and methods of use thereof |
US7718189B2 (en) * | 2002-10-29 | 2010-05-18 | Transave, Inc. | Sustained release of antiinfectives |
GB0322448D0 (en) * | 2003-09-25 | 2003-10-29 | Lamellar Therapeutics Ltd | Using lamellar bodies to modify linear biological macro molecules |
US7854943B2 (en) * | 2004-06-24 | 2010-12-21 | Idexx Laboratories | Phospholipid gel compositions for drug delivery and methods of treating conditions using same |
CN1634358A (zh) * | 2004-11-04 | 2005-07-06 | 杨雪 | 含抗微生物、抗病毒天然精油和磷脂类组合物 |
WO2008066631A2 (en) * | 2006-10-27 | 2008-06-05 | Athena Biotechnologies, Inc. | Methods of disrupting quorum sensing to affect microbial population cell density |
US20100210017A1 (en) * | 2007-01-12 | 2010-08-19 | Gill Ryan T | Compositions and methods for enhancing tolerance for the production of organic chemicals produced by microorganisms |
WO2014017233A1 (ja) * | 2012-07-27 | 2014-01-30 | 住友重機械工業株式会社 | 微生物用活性調節剤及び微生物の活性を調節する方法 |
-
2015
- 2015-06-23 GB GBGB1511058.8A patent/GB201511058D0/en not_active Ceased
-
2016
- 2016-06-23 KR KR1020187001721A patent/KR20180036958A/ko unknown
- 2016-06-23 JP JP2018518794A patent/JP2018518538A/ja active Pending
- 2016-06-23 ES ES16732720T patent/ES2754436T3/es active Active
- 2016-06-23 PL PL16732720T patent/PL3313377T3/pl unknown
- 2016-06-23 CN CN201680048546.1A patent/CN107920994A/zh active Pending
- 2016-06-23 LT LT16732720T patent/LT3313377T/lt unknown
- 2016-06-23 EP EP16732720.4A patent/EP3313377B1/en not_active Not-in-force
- 2016-06-23 PT PT167327204T patent/PT3313377T/pt unknown
- 2016-06-23 WO PCT/GB2016/051890 patent/WO2016207645A1/en active Application Filing
- 2016-06-23 CA CA2990743A patent/CA2990743A1/en not_active Abandoned
- 2016-06-23 RS RS20191484A patent/RS59551B1/sr unknown
- 2016-06-23 DK DK16732720T patent/DK3313377T3/da active
- 2016-06-23 US US15/739,288 patent/US20180169145A1/en not_active Abandoned
- 2016-06-23 HU HUE16732720A patent/HUE046510T2/hu unknown
- 2016-06-23 EP EP19192188.1A patent/EP3626232A1/en not_active Withdrawn
- 2016-06-23 BR BR112017027899-5A patent/BR112017027899A2/pt not_active Application Discontinuation
- 2016-06-23 MX MX2018000040A patent/MX2018000040A/es active IP Right Grant
- 2016-06-23 RU RU2017145630A patent/RU2017145630A/ru not_active Application Discontinuation
- 2016-06-23 AU AU2016281764A patent/AU2016281764A1/en not_active Abandoned
-
2017
- 2017-12-21 IL IL256498A patent/IL256498A/en unknown
- 2017-12-22 PH PH12017502432A patent/PH12017502432A1/en unknown
-
2018
- 2018-01-18 ZA ZA2018/00372A patent/ZA201800372B/en unknown
- 2018-06-15 HK HK18107780.9A patent/HK1248136A1/zh unknown
-
2019
- 2019-11-20 HR HRP20192091TT patent/HRP20192091T1/hr unknown
Also Published As
Publication number | Publication date |
---|---|
IL256498A (en) | 2018-02-28 |
CA2990743A1 (en) | 2016-12-29 |
AU2016281764A1 (en) | 2018-01-25 |
HK1248136A1 (zh) | 2018-10-12 |
RU2017145630A (ru) | 2019-07-23 |
ZA201800372B (en) | 2020-05-27 |
HRP20192091T1 (hr) | 2020-02-21 |
PT3313377T (pt) | 2019-10-31 |
EP3626232A1 (en) | 2020-03-25 |
EP3313377B1 (en) | 2019-08-21 |
WO2016207645A1 (en) | 2016-12-29 |
MX2018000040A (es) | 2019-01-10 |
PH12017502432A1 (en) | 2018-07-02 |
RS59551B1 (sr) | 2019-12-31 |
PL3313377T3 (pl) | 2020-01-31 |
JP2018518538A (ja) | 2018-07-12 |
GB201511058D0 (en) | 2015-08-05 |
US20180169145A1 (en) | 2018-06-21 |
DK3313377T3 (da) | 2019-11-11 |
KR20180036958A (ko) | 2018-04-10 |
ES2754436T3 (es) | 2020-04-17 |
EP3313377A1 (en) | 2018-05-02 |
HUE046510T2 (hu) | 2020-03-30 |
BR112017027899A2 (pt) | 2018-08-28 |
LT3313377T (lt) | 2019-11-25 |
CN107920994A (zh) | 2018-04-17 |
Similar Documents
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA92 | Acknowledgement of application withdrawn (lack of supplementary materials submitted) |
Effective date: 20210601 |